Combined anti-inflammatory and low-dose antiproliferative therapy for squamous cell carcinomas in recessive dystrophic epidermolysis bullosa.
Antonia ReimerS LuY HeL Bruckner-TudermanK Technau-HafsiF MeissCristina HasD von BubnoffPublished in: Journal of the European Academy of Dermatology and Venereology : JEADV (2019)